• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

不稳定因子(因子V)的测定与特性

The assay and properties of labile factor (factor V).

作者信息

QUICK A J

出版信息

J Clin Pathol. 1960 Nov;13(6):457-62. doi: 10.1136/jcp.13.6.457.

DOI:10.1136/jcp.13.6.457
PMID:13738700
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC480121/
Abstract

Human oxalated plasma stored at 4 degrees C. until the prothrombin time is increased beyond 60 sec. is a reliable medium for assaying labile factor (factor V) because its response to added labile factor corresponds quantitatively to that of plasma from patients with congenital deficiency of this factor. Such an agreement is not obtained with plasma stored at 37 degrees C. The stability of labile factor is closely associated with ionized calcium. The addition of thrombin to fresh oxalated plasma causes an apparent hyperactivity of labile factor, but this is completely removed by adsorption with Ca(3)(PO)(2). Oxalated plasma when adsorbed with Ca(3)(PO(4))(2) before treatment with thrombin does not develop this adventitious activity, nor does it occur in stored plasma treated with thrombin. The seemingly high labile factor activity in serum can be explained by the activation of this factor which is independent of labile factor but acts synergistically with it. The true labile factor concentration can be determined only after the accelerator is removed by adsorption with Ca(3)(PO(4))(2). A close agreement between the consumption of prothrombin and the loss of labile factor during clotting is observed.

摘要

保存在4℃直至凝血酶原时间延长超过60秒的人草酸盐血浆,是测定不稳定因子(因子V)的可靠介质,因为其对添加的不稳定因子的反应在数量上与先天性该因子缺乏患者的血浆反应一致。保存在37℃的血浆则无法得到这样的一致性结果。不稳定因子的稳定性与离子钙密切相关。向新鲜草酸盐血浆中加入凝血酶会导致不稳定因子出现明显的活性增强,但通过用Ca₃(PO₄)₂吸附可将其完全消除。在用凝血酶处理之前先用Ca₃(PO₄)₂吸附的草酸盐血浆不会产生这种异常活性,在用凝血酶处理的储存血浆中也不会出现这种情况。血清中看似较高的不稳定因子活性可以通过该因子的激活来解释,这种激活独立于不稳定因子,但与之协同作用。只有在用Ca₃(PO₄)₂吸附去除促凝剂后才能确定真正的不稳定因子浓度。在凝血过程中观察到凝血酶原消耗与不稳定因子丧失之间有密切的一致性。

相似文献

1
The assay and properties of labile factor (factor V).不稳定因子(因子V)的测定与特性
J Clin Pathol. 1960 Nov;13(6):457-62. doi: 10.1136/jcp.13.6.457.
2
The chemical state of the calcium reacting in the coagulation of blood.血液凝固过程中发生反应的钙的化学状态。
J Gen Physiol. 1948 Nov;32(2):191-202. doi: 10.1085/jgp.32.2.191.
3
"In vitro" correction of the severe factor V deficiency-related coagulopathy by a novel plasma-derived factor V concentrate.新型血浆源性因子 V 浓缩物对严重因子 V 缺乏相关凝血功能障碍的体外纠正作用。
Haemophilia. 2018 Jul;24(4):648-656. doi: 10.1111/hae.13465. Epub 2018 Mar 26.
4
Influence of time and temperature on coagulation analytes in stored plasma.时间和温度对储存血浆中凝血分析物的影响。
Clin Chem Lab Med. 1998 Jun;36(7):459-62. doi: 10.1515/CCLM.1998.077.
5
Heparin and low molecular weight heparins inhibit prothrombinase formation but not its activity in plasma.肝素和低分子量肝素可抑制凝血酶原酶的形成,但不抑制其在血浆中的活性。
Thromb Haemost. 1994 Dec;72(6):862-8.
6
Underestimation of plasma level of factor V coagulant activity and fibrinogen concentration together with prolonged prothrombin time, activated partial thromboplastin time and thrombin time can result from pre-analytical very low calcium level in citrated sample tube.枸橼酸盐样本管中分析前钙水平极低,可能导致凝血因子V促凝活性的血浆水平和纤维蛋白原浓度被低估,同时凝血酶原时间、活化部分凝血活酶时间和凝血酶时间延长。
Int J Lab Hematol. 2016 Feb;38(1):50-3. doi: 10.1111/ijlh.12434. Epub 2015 Sep 25.
7
Effect of a high-fat diet on the concentration of antihemophilic globulin and factor V.高脂饮食对抗血友病球蛋白和因子V浓度的影响。
Can Med Assoc J. 1962 Nov 10;87(19):1001-4.
8
Relationship between secretion of platelet Factor 4 and thrombin generation during in vitro blood clotting.体外血液凝固过程中血小板因子4分泌与凝血酶生成之间的关系。
J Clin Invest. 1980 Feb;65(2):307-13. doi: 10.1172/JCI109673.
9
Blood coagulation in fish.鱼类的血液凝固
Am J Physiol. 1962 Nov;203:964-70. doi: 10.1152/ajplegacy.1962.203.5.964.
10
The inhibition of thrombin-dependent positive-feedback reactions is critical to the expression of the anticoagulant effect of heparin.抑制凝血酶依赖性正反馈反应对于肝素抗凝作用的发挥至关重要。
Biochem J. 1987 Apr 15;243(2):579-88. doi: 10.1042/bj2430579.

引用本文的文献

1
The Role of Proaccelerin in Human Blood Coagulation. Evidence that Proaccelerin Is Converted to a Prothrombin-converting Principle by Activated Stuart Factor: With Notes on the Anticoagulant Action of Soybean Trypsin Inhibitor, Protamine Sulfate, and Hexadimethrine Bromide.加速素在人体血液凝固中的作用。关于加速素被活化的斯图尔特因子转化为凝血酶原转化因子的证据:兼论大豆胰蛋白酶抑制剂、硫酸鱼精蛋白和溴化己二甲铵的抗凝作用。
J Clin Invest. 1965 Feb;44(2):302-14. doi: 10.1172/JCI105144.
2
"THROMBOCYTOPENIC SERUM": AN ARTIFICIAL FACTOR VIII-DEFICIENT REAGENT.“血小板减少血清”:一种人工制备的缺乏凝血因子VIII的试剂。
J Clin Pathol. 1964 Mar;17(2):188-90. doi: 10.1136/jcp.17.2.188.
3
The contact system contributes to hypotension but not disseminated intravascular coagulation in lethal bacteremia. In vivo use of a monoclonal anti-factor XII antibody to block contact activation in baboons.接触系统在致死性菌血症中导致低血压,但不引起弥散性血管内凝血。在狒狒体内使用单克隆抗凝血因子XII抗体来阻断接触激活。
J Clin Invest. 1993 Jan;91(1):61-8. doi: 10.1172/JCI116201.
4
Potentiation of endotoxin-induced consumptive coagulopathy by lead acetate administration.醋酸铅给药对内毒素诱导的消耗性凝血病的增强作用。
Infect Immun. 1974 Dec;10(6):1343-9. doi: 10.1128/iai.10.6.1343-1349.1974.
5
The pathogenesis of leptospirosis I. Hemorrhages in experimental leptospirosis in guinea pigs.钩端螺旋体病的发病机制I. 豚鼠实验性钩端螺旋体病中的出血
Can J Comp Med. 1977 Apr;41(2):174-81.

本文引用的文献

1
A Prothrombin Conversion Accelerator in Serum.血清中的凝血酶原转化加速因子。
Science. 1949 May 27;109(2839):545. doi: 10.1126/science.109.2839.545.
2
HUMAN PROTHROMBIN: QUANTITATIVE STUDIES ON THE PLASMA LABILE FACTOR AND THE RESTORATIVE EFFECTS OF NORMAL, HYPOFI-BRINOGENEMIC, AND HEMOPHILIC PLASMA ON THE PROTHROMBIN OF STORED PLASMA.人凝血酶原:关于血浆不稳定因子的定量研究以及正常血浆、低纤维蛋白原血症血浆和血友病血浆对储存血浆凝血酶原的恢复作用
J Clin Invest. 1949 Jan;28(1):24-31. doi: 10.1172/JCI102048.
3
The prothrombin conversion accelerator of serum (SPCA): its partial purification and its properties compared with serum AC-globulin.血清凝血酶原转化加速因子(SPCA):其部分纯化及其与血清AC球蛋白相比的特性。
J Clin Invest. 1950 Jul;29(7):881-95. doi: 10.1172/JCI102322.
4
Effect of sodium citrate and heparin on I removal of calcium from blood and serum by amberlite.柠檬酸钠和肝素对通过琥石离子交换树脂从血液和血清中去除钙的影响。
J Biol Chem. 1950 May;184(1):105-8.
5
Hematologic and coagulation studies in various animal species.
J Lab Clin Med. 1959 Jun;53(6):866-75.
6
Factor-V consumption during blood coagulation.血液凝固过程中因子V的消耗。
Br J Haematol. 1956 Apr;2(2):153-9. doi: 10.1111/j.1365-2141.1956.tb06823.x.
7
A modification for routine laboratory use of Stefanini's method of estimating factor V activity in human oxalated plasma.斯特凡尼尼(Stefanini)法用于估算人草酸盐血浆中因子V活性的常规实验室应用改良法。
J Clin Pathol. 1953 Feb;6(1):34-8. doi: 10.1136/jcp.6.1.34.